Townsend Asset Management’s Pfizer PFE Stock Holding History

Townsend Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,742	Closed	-$211K	–	196
2023 Q2	$211K	Hold	5,742	–	–	0.1%	125
2023 Q1	$234K	Hold	5,742	–	–	0.12%	121
2022 Q4	$294K	Buy	5,742 +1,002	+21%	+$48K	0.15%	106
2022 Q3	$207K	Hold	4,740	–	–	0.12%	125
2022 Q2	$249K	Buy	+4,740	New	+$242K	0.13%	125
2022 Q1	–	Sell	-4,899	Closed	-$289K	–	213
2021 Q4	$289K	Buy	4,899 +155	+3%	+$7.68K	0.14%	112
2021 Q3	$204K	Buy	+4,744	New	+$210K	0.11%	139

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Townsend Asset Management's PFE Position: Q3 2023 in Review

Townsend Asset Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,742 shares — an estimated $211K sold.

Townsend Asset Management first reported a position in PFE in Q3 2021 and held it in 7 quarters. The position peaked at $294K in Q4 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Townsend Asset Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Townsend Asset Management sold 5,742 Pfizer shares in Q3 2023, an estimated $211K.
Townsend Asset Management first reported a position in Pfizer in Q3 2021 and held it in 7 quarters.
Townsend Asset Management's Pfizer position peaked at $294K in Q4 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Townsend Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.